In addition, the current study confirmed that the MAPK signalling pathway is involved in the development of BPD, and the long noncoding RNAs (lncRNAs) H19 and PAR2 were identified as potential targets for the treatment of BPD [34, 35]. The gene discussed is H19; the disease is bronchopulmonary dysplasia.